BE Health and Taipei Medical University have co-launched the POC (Proof of Clinical Evidence) Program that focuses on product or prototype-ready startups that are looking for traction in the Asian market. Based in Taipei, Taiwan, we leverage the unique strengths of our ecosystem to position our accelerator program as the gateway to Asia. Our unparalleled access to hospital facilities, research institutes, investors, healthcare experts, and other industry stakeholders help you secure funding and expand your market to Japan, Greater China, and SEA. Taipei Medical University has five world-class hospitals under their management, with a focus on innovation and smart hospitals, establishing themselves as the ideal Asian healthcare partner.
Selected teams may gain access to international market expansion opportunities through collaborations with the MOHW One Country One Center Program (Thailand–Laos, Philippines), as well as global partners including SingHealth A.L.I.C.E (Singapore), Tohoku University (Japan), and Ignity (Belgium).
These partnerships enable startups to enter international markets and build connections with leading global healthcare institutions, investors, and key industry stakeholders.
PoC (Proof of Clinical Evidence) startup focus
Opportunity to be funded up to $200K market expansion
20-24 weeks
Demo site at hospital
Local& International (Japan, China, SEA, US) exposure
Opportunity to get the TMU trial program support
※Top academic and healthcare system in Taiwan
※Vast clinical resources
※Extensive experiences in collaborating with digital health and AI companies
※The world's first international safety hospital certification, 800 beds.
※The most complete international standardization, 743 beds.
※The first BOT(Build-Operate-Transfer) hospital in the country, with a total of 1,600 beds.
※The first international neuro medical center in Taiwan.
※Orthopedics Mainly, General Medicine.
※High-quality cancer center integrating cancer medical research, education, and clinical.
※Telehealth
※Precision Medicine
※Next Generation Sequencing
※Smart Hospital
※Medical Imaging
※Auxiliary Diagnosis
※Health Management
※Drug Discovery
※Advanced Biomaterials
※Monitoring & Therapeutics
※Delivery Platform
※IVD diagnosis